Monday, July 09, 2018 12:47:37 PM
Like both of you I thought that a partnership between Pluristem and Lonza seemed a distinct possibility. Allo, I do not recall you ever stating that your hypothesis was anything other than that and the fact that a different (and more powerful) company has entered a partnership with Pluristem is both surprising and unexpected (as far as I am concerned). I think the latest developments are seriously impressive and very reassuring and I agree with you zzaatt that hopefully this may result in a "more expeditious move toward patient benefit and clinical availability".
A nice start to the week, especially since I was convinced that there may not be any substantial Pluristem news until after the summer.
HappyBee
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM